The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidhas signed a licensing agreement with the United Nations-backed Medicines Patent Pool that will allow more companies to manufacture generic versions of its experimental oral antiviral COVID-19 treatment, the U.S. drugmaker and the organization announced on Wednesday.
The U.S. Food and Drug Administration is considering emergency use authorization of the medicine, which was shown in"This is the first transparent, public health-driven voluntary license for a COVID-19 medical technology," Merck and MPP said in a joint statement. Medical charity Medecins Sans Frontieres , however, expressed disappointment with the limitations of the license as its territory excludes nearly half of the world's population and upper-middle-income countries with robust manufacturing capacities, such as Brazil and China.
Giving it away..no wonder NEW DELHI (Reuters) - Merck & Co's experimental antiviral drug molnupiravir has not shown 'significant efficacy' against moderate COVID-19, Drug Controller General of India said 'There is no significant efficacy against moderate COVID and mild cases,'
Biz Merck donated to Africa a drug for 'river blindness,' that it could not sell to developed countries, but this is the 1st donation of a drug that would sell well.. - Merck signs pact to broaden generic manufacturing of COVID-19 pill
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Record case rates in Wales and long Covid study begins in ScotlandFive things you need to know about the coronavirus pandemic this Tuesday evening.
Source: bbchealth - 🏆 143. / 63 Read more »
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profitU.S. pharmaceutical giant Merck has agreed to share its license with a non-profit so that its experimental covid-19 drug, molnupiravir, can be manufactured widely around the world in a deal that would expand access in more than 100 countries
Source: washingtonpost - 🏆 95. / 72 Read more »
Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-OldsModerna said it would submit the results from an interim study to health regulators in the U.S., Europe and elsewhere in seeking authorization for 6- to 11-year-olds. Also note the use of “induced the desired immune response” rather than “protected them from COVID”. If they’re like Pfizer, that’s because not enough kids got sick (in either group) to test that. 🤣🤣🤣
Source: WSJ - 🏆 98. / 63 Read more »
Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said. Have they submitted the safety data?
Source: HuffPostWomen - 🏆 27. / 68 Read more »
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults. My Kids will never get the vaccine. That is freakin ass LIE! All vaccines are deadly poisin. Vaccines are killing people and newborn babies. So if you wanna die, and/or your newborn die DO NOT TAKE THE VACCINES [they are killing people. That is 100% TRUE! Child abuse.
Source: TODAYshow - 🏆 389. / 55 Read more »
EU regulator starts real-time review of Merck's COVID-19 pillU.S. drugmaker Merck & Co Inc said on Monday the European Union's drug regulator has initiated a real-time review of its experimental COVID-19 antiviral drug for adults.
Source: Reuters - 🏆 2. / 97 Read more »